MYND Lifesciencs Inc. (MYNDF)

0.0729 0.0000 (0.00%) At close: 10:03AM EDT

MYND Lifesciencs Inc.

733 Finns Road
Kelowna, BC V1X 5B7
Canada
403 559 6779
https://www.myndsciences.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Wilfred A. Jefferies	Co-Founder, Chairman & Chief Science Officer	N/A	N/A	1958
Dr. Lyle Oberg M.D.	Co-Founder, CEO & Director	N/A	N/A	1960
Mr. Lih-Ming Tam	Interim CFO & Sr. Controller	N/A	N/A	N/A
Dr. Chaahat S.B Singh	Sr. Operations & Research Mang.	N/A	N/A	N/A
Mr. Luke Warkentin	VP of Corp. Devel.	N/A	N/A	N/A
Dr. Iryna Saranchova Ph.D.	Chief Clinical Officer	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. The company was incorporated in 2018 and is headquartered in Kelowna, Canada.

Corporate Governance

MYND Lifesciencs Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.